Status:
COMPLETED
An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-78 years
Phase:
PHASE3
Brief Summary
The purpose of this investigational study is to determine the safety and effectiveness of an investigational drug in patients with type 2 diabetes mellitus (a specific type of diabetes).
Detailed Description
The duration of treatment is 104 weeks.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients who are at least 18 years of age and not older than 78 with type 2 diabetes mellitus
Exclusion
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
1172 Patients enrolled
Trial Details
Trial ID
NCT00094770
Start Date
September 1 2004
End Date
May 1 2007
Last Update
August 26 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.